The AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenic stroke randomized trial: Rationale and methods

Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source

(2018) Robert G. Hart et al.   NEW ENGLAND JOURNAL OF MEDICINE

Embolic Stroke of Undetermined Source

(2017) Robert G. Hart et al.   STROKE

Effect of apixaban on brain infarction and microbleeds: AVERROES-MRI assessment study

(2016) Martin J. O'Donnell et al.   AMERICAN HEART JOURNAL

Apixaban for treatment of embolic stroke of undetermined source (ATTICUS randomized trial): Rationale and study design

(2016) Tobias Geisler et al.   International Journal of Stroke

Association Between Nonstenosing Carotid Artery Plaque on MR Angiography and Acute Ischemic Stroke

(2016) Ajay Gupta et al.   JACC-Cardiovascular Imaging

Electrocardiographic left atrial abnormality and stroke subtype in the atherosclerosis risk in communities study

(2015) Hooman Kamel et al.   ANNALS OF NEUROLOGY

Nebivolol for Improving Endothelial Dysfunction, Pulmonary Vascular Remodeling, and Right Heart Function in Pulmonary Hypertension

(2015) Frédéric Perros et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Electrocardiographic Left Atrial Abnormality and Risk of Stroke

(2015) Hooman Kamel et al.   STROKE

Left Atrial Enlargement and Stroke Recurrence

(2015) Shadi Yaghi et al.   STROKE

Magnetic Resonance Angiography Detection of Abnormal Carotid Artery Plaque in Patients With Cryptogenic Stroke

(2015) A. Gupta et al.   Journal of the American Heart Association

Aggressive Risk Factor Reduction Study for Atrial Fibrillation and Implications for the Outcome of Ablation

(2014) Rajeev K. Pathak et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Embolic strokes of undetermined source: the case for a new clinical construct

(2014) Robert G Hart et al.   LANCET NEUROLOGY

Atrial Fibrillation in Patients with Cryptogenic Stroke

(2014) David J. Gladstone et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cryptogenic Stroke and Underlying Atrial Fibrillation

(2014) Tommaso Sanna et al.   NEW ENGLAND JOURNAL OF MEDICINE

Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack

(2014) Walter N. Kernan et al.   STROKE

N-Terminal Pro–B-type Natriuretic Peptide and Stroke Risk

(2014) Mary Cushman et al.   STROKE

P-Wave Morphology and the Risk of Incident Ischemic Stroke in the Multi-Ethnic Study of Atherosclerosis

(2014) Hooman Kamel et al.   STROKE

Clopidogrel Plus Aspirin Versus Warfarin in Patients With Stroke and Aortic Arch Plaques

(2014) Pierre Amarenco et al.   STROKE

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

(2013) Christian T Ruff et al.   LANCET

Amino Terminal Pro–B-Type Natriuretic Peptide, Secondary Stroke Prevention, and Choice of Antithrombotic Therapy

(2013) W.T. Longstreth et al.   STROKE

Troponin T, N-Terminal Pro–B-Type Natriuretic Peptide, and Incidence of Stroke

(2013) Aaron R. Folsom et al.   STROKE

Minimal sufficient balance—a new strategy to balance baseline covariates and preserve randomness of treatment allocation

(2012) Wenle Zhao et al.   STATISTICAL METHODS IN MEDICAL RESEARCH

Prevalence of Nonstenosing, Complicated Atherosclerotic Plaques in Cryptogenic Stroke

(2012) Tobias M. Freilinger et al.   JACC-Cardiovascular Imaging

Stenting versus Aggressive Medical Therapy for Intracranial Arterial Stenosis

(2011) Marc I. Chimowitz et al.   NEW ENGLAND JOURNAL OF MEDICINE

Apixaban in Patients with Atrial Fibrillation

(2011) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Apixaban versus Warfarin in Patients with Atrial Fibrillation

(2011) Christopher B. Granger et al.   NEW ENGLAND JOURNAL OF MEDICINE